Therapy of Human T-Cell Acute Lymphoblastic Leukaemia With a Combination of Anti-Cd7 and Anti-Cd38-Saporin Immunotoxins Is Significantly Better Than Therapy With Each Individual Immunotoxin

British Journal of Cancer - United Kingdom
doi 10.1054/bjoc.2000.1633
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Anti-Cd7 Antibody and Immunotoxin Treatment of Human CD7+T-cell Leukaemia Is Significantly Less Effective in NOD/LtSz-scid Mice Than in CB.17 Scid Mice

British Journal of Cancer
Cancer ResearchOncology
2000English

Phase I/Ii Trial of a Combination of Anti-Cd3/Cd7 Immunotoxins for Steroid-Refractory Acute Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

CAR T Cell Therapy in B-Cell Acute Lymphoblastic Leukaemia: Insights From Mathematical Models

2020English

Efficacy and Safety of Humanized Anti-Cd19-Car-T Therapy Following Intensive Lymphodepleting Chemotherapy for Refractory/Relapsed B Acute Lymphoblastic Leukaemia

British Journal of Haematology
Hematology
2020English

Simulation and Stability Assessment of Anti-EpCAM Immunotoxin for Cancer Therapy

Advanced Pharmaceutical Bulletin
ToxicologyPharmaceuticsPharmacologyPharmaceutical Science
2018English

Combination of Angiotensin-(1–7) With Perindopril Is Better Than Single Therapy in Ameliorating Diabetic Cardiomyopathy

Scientific Reports
Multidisciplinary
2015English

Glucocorticoid Resistance in T-Lineage Acute Lymphoblastic Leukaemia Is Associated With a Proliferative Metabolism

British Journal of Cancer
Cancer ResearchOncology
2009English

Role of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia

Memo - Magazine of European Medical Oncology
OncologyHematology
2019English

Anti-Cancer Effects of Oncolytic Viral Therapy Combined With Photodynamic Therapy in Human Pancreatic Cancer Cell Lines

The Lancet
Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy